Omeros | OMER - Market Capitalization


Omeros reported $685.2M in Market Capitalization this April of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Adma Biologics USD 4.34B 845M Dec/2025
Alnylam Pharmaceuticals USD 52.54B 7.24B Dec/2025
BioMarin Pharmaceutical USD 11.42B 1.02B Dec/2025
Cytokinetics USD 7.77B 1.19B Dec/2025
Gilead Sciences USD 152.28B 14.55B Dec/2025
Heron Therapeutics USD 238M 7M Dec/2025
Insmed USD 37.12B 6.68B Dec/2025
Knight Therapeutics CAD 600.53M 14.56M Dec/2025
MacroGenics USD 102M 4M Dec/2025
Pacira USD 1.06B 94M Dec/2025
Pfizer USD 141.57B 6.48B Dec/2025
Sarepta Therapeutics USD 2.26B 238M Dec/2025
United Therapeutics USD 20.98B 2.02B Dec/2025
Vertex Pharmaceuticals USD 115.03B 14.61B Dec/2025